ModAstera has been selected as one of 15 finalists in the Qualcomm AI Program for Innovators (QAIPI) 2025 - APAC, receiving 6 months of mentorship and platform support to accelerate AI development.
By ModAstera
23 May 2025
We are thrilled to announce that ModAstera has been selected as one of 15 standout startups across Japan, Singapore, and Korea to participate in Qualcomm’s AI Program for Innovators (QAIPI) 2025!
The QAIPI 2025 – APAC is a competitive program launched by Qualcomm Technologies, aimed at empowering startups and individual developers across Asia-Pacific to build scalable, on-device AI solutions. We will receive through 6 months of 1:1 mentorship, direct access to Qualcomm’s hardware and platform expertise, and resources to bring cutting-edge products to market faster.
This recognition marks a significant milestone in our mission to transform medical AI with MAEA, the world’s first Medical AI Engineering Agent, built to automate and accelerate compliant AI development in healthcare.
🔗Learn more about the Qualcomm AI Program for Innovators here: :https://www.qualcomm.com/ai-program-for-innovators/apac
Sizing a medical AI dataset is arithmetic. Keeping that dataset provable, versioned, and reusable across years of development is the part that fails, and it is what MAEA is built to hold together.
There is no single number. There is a data budget, a timeline, and an endpoint that finally makes the number computable. A full report on sizing evidence for regulated medical AI.
A practical guide to testing whether a locked medical-AI system transfers beyond its development data, including cohort design, thresholds, subgroup analysis, workflow evaluation, and failure review.
